Peritoneal dissemination is diagnosed in 10–25% of colorectal cancer patients. Selected
patients are treated with cytoreductive surgery and hyperthermic intraperitoneal …

When colorectal cancer (CRC) metastasizes, this is mostly to the liver via the portal
circulation. In addition, 10–25% of CRC patients eventually show metastases in the …

Peritoneal metastases frequently occur in different gastrointestinal cancers and have a poor
prognosis. It is known that surgical injury promotes tumor growth and local recurrence rates …

The interaction between gastric cancer (GC) cells and the peritoneum is a critical event in
peritoneal dissemination. The molecular mechanisms of this dissemination, however …

Abstract Development of peritoneal metastasis is a significant issue in the treatment of
abdominal cancers. Primary interaction between tumour cells and the mesothelium is a vital …

Peritoneal metastasis (PM) from colorectal cancer (CRC) carries a significant mortality rate
for patients and treatment is challenging. The development of PM is a multistep process …

The peritoneum is a common site of dissemination in patients with colorectal cancer. In order
to identify high-risk patients and improve therapeutic strategies, a better understanding of …

Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) is a cell–cell adhesion
protein conferring heterotypic and homotypic interactions between cells of the same type …

Peritoneal metastases confer the worst survival among all sites in patients with metastatic
colorectal cancer. They develop largely through transcoelomic spread, with a sequence of …

Peritoneal metastasis is a malignant disease which originated from several gastrointestinal
and gynecological carcinomas and has been leading to a suffering condition in patients for …